نتایج جستجو برای: farnesyl dipho

تعداد نتایج: 1579  

2016
Liyang Yang Chonglong Wang Jia Zhou Seon-Won Kim

BACKGROUND Protoilludene is a valuable sesquiterpene and serves as a precursor for several medicinal compounds and antimicrobial chemicals. It can be synthesized by heterologous expression of protoilludene synthase in Escherichia coli with overexpression of mevalonate (MVA) or methylerythritol-phosphate (MEP) pathway, and farnesyl diphosphate (FPP) synthase. Here, we present E. coli as a cell f...

Journal: :Journal of medicinal chemistry 2010
Steven Fletcher Erin Pusateri Keaney Christopher G Cummings Michelle A Blaskovich Michael A Hast Matthew P Glenn Sung-Youn Chang Cynthia J Bucher Ryan J Floyd William P Katt Michael H Gelb Wesley C Van Voorhis Lorena S Beese Said M Sebti Andrew D Hamilton

A potent class of anticancer, human farnesyltransferase (hFTase) inhibitors has been identified by "piggy-backing" on potent, antimalarial inhibitors of Plasmodium falciparum farnesyltransferase (PfFTase). On the basis of a 4-fold substituted ethylenediamine scaffold, the inhibitors are structurally simple and readily derivatized, facilitating the extensive structure-activity relationship (SAR)...

Journal: :Organic & biomolecular chemistry 2006
Silvia Forcat Rudolf K Allemann

The mechanistic details of the cyclisation of farnesylpyrophosphate (FPP) by aristolochene synthase (AS) from Penicillium roqueforti have only recently begun to emerge, mainly through the analysis of the reaction products generated by AS-mutants. The reaction proceeds through several intermediates including germacrene A and eudesmane cation. Previous work suggested that the side chain of phenyl...

Journal: :Cancer research 2006
Adam I Marcus Aurora M O'Brate Ruben M Buey Jun Zhou Shala Thomas Fadlo R Khuri Jose Manuel Andreu Fernando Díaz Paraskevi Giannakakou

The combination of farnesyltransferase inhibitors (FTIs) and taxanes has been shown to result in potent antiproliferative and antimitotic synergy. Recent phase I and II clinical trials have shown that this combination shows clinical activity in taxane-refractory or taxane-resistant cancer patients. To understand the mechanism behind these clinical observations, we used a cancer cell model of pa...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید